Document is current
Any future updates will be listed below
-
Authors
Howarth, Karen D. https://orcid.org/0000-0002-1124-4583
Mirza, Tashfina https://orcid.org/0000-0002-5780-9789
Cooke, Susanna L. https://orcid.org/0000-0002-0955-0346
Chin, Suet-Feung https://orcid.org/0000-0001-5697-1082
Pole, Jessica C. https://orcid.org/0000-0002-5651-302X
Turro, Ernest https://orcid.org/0000-0002-1820-6563
Eldridge, Matthew D. https://orcid.org/0000-0002-5799-8911
Garcia, Raquel Manzano https://orcid.org/0000-0002-5124-8992
Rueda, Oscar M. https://orcid.org/0000-0003-0008-4884
Boursnell, Chris https://orcid.org/0000-0002-3494-4451
Abraham, Jean E. https://orcid.org/0000-0003-0688-4807
Caldas, Carlos https://orcid.org/0000-0003-3547-1489
Edwards, Paul A. W. https://orcid.org/0000-0002-4789-3374
-
Funding
Funding for this research was provided by:
Cancer Research UK
Breast Cancer Now
Addenbrookes Charitable Trust
Mark Foundation For Cancer Research
Addenbrooke's Charitable Trust, Cambridge University Hospitals
- License Information
-
More Information
Article History
Received: 13 September 2020
Accepted: 30 November 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: Ethical approval for the Cambridge Personalised Breast Cancer Program was granted by the East of England (Cambridge Central) Health Research Authority (refs 16/EE/0100 and 18/EE/0251).
: Not applicable
: Subsequent to this work, KDH and JCP were employed respectively by Inviata and Illumina, which have interests in cancer diagnostics.
